Measures of Success - Applied Clinical Trials

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
See our 2009 Buyers Guide Digital Edition.
Find Pharma Search Engine
Measures of Success
Paying attention to key performance metrics will eventually reduce global clinical development times and deliver innovative treatments earlier.
Apr 1, 2005
By: Johanna Schenk, Antal K. Hajos
Applied Clinical Trials

« Previous
1234567

11. Tufts Center for the Study of Drug Development Impact Report July 1999; 1.

12. M.J. Lamberti, ed., An Industry in Evolution, 4th Ed. (Boston, MA, Thomson CenterWatch, 2003).

Acknowledgement The authors would like to thank Steve Demas, ALTANA Pharma Inc., Canada for helpful suggestions and proofreading of the manuscript.

Dr. med. Johanna Schenk,*FFPM, is senior partner and managing director, PharmaProjekthaus GmbH & Co. KG, Altenhoeferallee 3, 60438 Frankfurt am Main, Germany, +49 69 951172-10, fax +49 69 951172-11, email: johanna.schenk@pharmaprojekthaus.com.
Antal K. Hajos is director clinical development/clinical operations, ALTANA Pharma AG, Byk-Gulden-Strasse 2, 78467 Konstanz, Germany.

« Previous
1234567

ADVERTISEMENT

ADVERTISEMENT

Evotec AG and Ono Pharmaceutical Tighten Collaborations
GSPI and Abridge Build Development Bridge to India
Time to Review ICH GCP Guidelines, Say ICR Members
TFS Trial Form Support International and Karolinska University Hospital Prolong Partnership
Sparta Systems Strengthens Asia-Pacific Presence
FindPharma
Featured Jobs

More Jobs

Survey
Would you ever consider working as a freelance clinical research professional?
Yes, I'd love to
Yes, but would never do it
No, but may have to
Absolutely not, no stability
Yes, I'd love to
75%
Yes, but would never do it
8%
No, but may have to
17%
Absolutely not, no stability
0%
View Results
Source: Applied Clinical Trials, 4/1/2005
Click here